Top Abstract Purchase Related
Home
>
Node
>
Subnode

Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6

Rosenfeld, C.S.; Rybka, W.B.; Weinbaum, D.; Carrigan, D.R.; Knox, K.K.; Andrews, D.F.; Shadduck, R.K.

Experimental Hematology 23(7): 626-629

1995

ISSN/ISBN: 0301-472X
PMID: 7601254
Document Number: 443317
Hematopoietic effects of human Herpesvirus-6 (HHV-6) infection following bone marrow transplantation (BMT) include delayed engraftment and early myelosuppression. Variant A has not been isolated after BMT. A case of graft failure is reported following an HLA-identical BMT for chronic myelogenous leukemia (CML) in chronic phase. Evaluation of bone marrow during the period of graft failure revealed variants A and B of HHV-6 by culture, immunofluorescence, polymerase chain reaction (PCR), and immunohistochemistry. Evidence for other cases of graft failure, including cytomegalovirus (CMV), could not be found. A hypothesis is proposed that late graft failure in this case was due to variant A of HHV-6.

Document emailed within 1 workday
Secure & encrypted payments

Zakrzewski, J.L. 2002: Successful management of impending late graft failure in a thalassemic bone marrow transplant recipient Haematologica 87(10): Ecr32
Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77
Vannucchi, A.M.; Bosi, A.; Laszlo, D.; Guidi, S.; Saccardi, R.; Rossi-Ferrini, P. 1995: Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSF Haematologica 80(4): 341-343
Lehner, P.J.; Rawal, B.; Hoyle, C.; Cohen, J. 1992: Dual infection with Pneumocystis carinii and respiratory viruses complicating bone marrow transplantation Bone Marrow Transplantation 9(3): 213-215
Ozkalay, N.; Ozacar, T.; Aşçi, G.ül.; Töz, H.üs.; Kansoy, S.ş 2003: Human herpesvirus 6 infections in kidney and bone marrow/stem cell transplant recipients Mikrobiyoloji Bulteni 37(2-3): 179-186
Olszewski, W.L.; Lukomska, B.; Durlik, M.; Namyslowski, A.; Cybulska, E. 1994: Bone marrow cells transplanted in suspension or in vascularized bone graft repopulate not only bone marrow but also lymphoid organs Transplantation Proceedings 26(6): 3319-3320
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Oudshoorn, M.; Falkenburg, J.H.; Ebeling, L.J.; Haak, H.L.; Wijermans, P.W.; Fibbe, W.E.; Willemze, R.; van Rood, J.J. 1996: Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft Bone Marrow Transplantation 18(2): 461-463
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Amiel, J.L.; Mathe, G.; Schwarzenberg, L.; Schneider, M.; Choay, J.; Trolard, P.; Hayat, M.; Schlumberger, J.R.; Jasmin, C. 1970: Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias La Presse Medicale 78(40): 1727-1734
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Cahn, J.Y.; Hervé, P.; Flesch, M.; Plouvier, E.; Racadot, E.; Montcuquet, P.; Noir, A.; Peters, A.; Leconte des Floris, R. 1986: T immunodepletion of the graft in allogeneic bone marrow grafts. Efficacy in the prevention of graft-versus-host reaction Presse Medicale 15(25): 1204
Hu, Y.H.; Li, X.R. 2000: Graft of AAA bone combined with autologous red bone marrow for treatment of bone defects Hunan Yi Ke da Xue Xue Bao 25(2): 157-158
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Suttorp, M.; Schmitz, N.; Prange, E.; Oster, W.; Löffler, H.; Schaub, J.; Ganser, A. 1991: Remission of juvenile chronic myeloid leukemia following graft failure of an unrelated marrow transplant and autologous recovery of marrow function promoted by GM-CSF and IL-3 Leukemia 5(8): 723-725
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Speck, B.; Irlé, C. 1983: Transplantation of bone marrow. Marrow graft Revue Medicale de la Suisse Romande 103(2): 129-140
Rogova, E.M.; Domracheva, E.V. 1983: Cultivation of fibroblasts of human cadaveric bone marrow and bone marrow preserved at 4 degrees C Terapevticheskii Arkhiv 55(8): 131-132
Mumcuoglu, M.; Naparstek, E.; Slavin, S. 1990: The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow Bone Marrow Transplantation 5(3): 153-158